4//SEC Filing
Rajangam Kanya 4
Accession 0000899243-21-032196
CIK 0001787400other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 5:17 PM ET
Size
9.3 KB
Accession
0000899243-21-032196
Insider Transaction Report
Form 4
Nkarta, Inc.NKTX
Rajangam Kanya
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$0.41/sh+10,000$4,100→ 10,000 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-05−10,000→ 44,054 totalExercise: $0.41Exp: 2028-12-06→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-08-05$37.28/sh−10,000$372,800→ 0 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
- [F2]This transaction was executed in multiple trades at prices ranging from $37.02 to $37.63, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on December 3, 2022.
Documents
Issuer
Nkarta, Inc.
CIK 0001787400
Entity typeother
Related Parties
1- filerCIK 0001816676
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 5:17 PM ET
- Size
- 9.3 KB